Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITCI |
---|---|---|
09:32 ET | 5213 | 60.57 |
09:33 ET | 4135 | 61.345 |
09:35 ET | 1142 | 61.345 |
09:37 ET | 700 | 61.36 |
09:39 ET | 1105 | 61.52 |
09:42 ET | 300 | 61.22 |
09:44 ET | 600 | 61.09 |
09:46 ET | 700 | 61.28 |
09:48 ET | 300 | 61.515 |
09:50 ET | 1450 | 61.63 |
09:51 ET | 100 | 61.6 |
09:53 ET | 2820 | 61.42 |
09:55 ET | 900 | 61.435 |
09:57 ET | 1000 | 61.56 |
10:00 ET | 2533 | 61.415 |
10:02 ET | 4700 | 61.73 |
10:04 ET | 2083 | 61.6 |
10:06 ET | 1100 | 61.68 |
10:08 ET | 1011 | 61.645 |
10:09 ET | 3510 | 61.615 |
10:11 ET | 1600 | 61.45 |
10:13 ET | 11600 | 61.385 |
10:15 ET | 1086 | 61.585 |
10:18 ET | 1600 | 61.695 |
10:20 ET | 940 | 61.7 |
10:22 ET | 2300 | 61.55 |
10:24 ET | 2108 | 61.515 |
10:26 ET | 772 | 61.6 |
10:27 ET | 707 | 61.6 |
10:29 ET | 731 | 61.485 |
10:31 ET | 1009 | 61.6 |
10:33 ET | 400 | 61.43 |
10:36 ET | 901 | 61.27 |
10:38 ET | 1500 | 61.175 |
10:40 ET | 200 | 61.175 |
10:42 ET | 818 | 61.075 |
10:44 ET | 1900 | 61.105 |
10:45 ET | 600 | 61.115 |
10:47 ET | 10920 | 61.06 |
10:49 ET | 1450 | 60.85 |
10:51 ET | 1200 | 60.895 |
10:54 ET | 800 | 60.94 |
10:56 ET | 1665 | 60.93 |
10:58 ET | 1000 | 60.93 |
11:00 ET | 1272 | 60.77 |
11:02 ET | 3721 | 60.81 |
11:03 ET | 1900 | 60.81 |
11:05 ET | 4800 | 60.85 |
11:07 ET | 300 | 60.86 |
11:09 ET | 900 | 60.71 |
11:12 ET | 1179 | 60.52 |
11:14 ET | 2333 | 60.38 |
11:16 ET | 1100 | 60.28 |
11:18 ET | 1984 | 60.28 |
11:20 ET | 500 | 60.2 |
11:21 ET | 3100 | 60.32 |
11:23 ET | 9499 | 60.34 |
11:25 ET | 2940 | 60.215 |
11:27 ET | 1600 | 60.12 |
11:30 ET | 1000 | 60.21 |
11:32 ET | 1900 | 60.23 |
11:34 ET | 800 | 60.175 |
11:36 ET | 1018 | 60.255 |
11:38 ET | 605 | 60.16 |
11:39 ET | 1600 | 60.04 |
11:41 ET | 400 | 60.05 |
11:43 ET | 1400 | 59.93 |
11:45 ET | 400 | 59.88 |
11:48 ET | 520 | 59.83 |
11:50 ET | 1300 | 59.95 |
11:52 ET | 600 | 59.91 |
11:54 ET | 561 | 59.82 |
11:56 ET | 824 | 59.87 |
11:57 ET | 100 | 59.97 |
11:59 ET | 4495 | 60.09 |
12:01 ET | 1402 | 60.02 |
12:03 ET | 1800 | 60 |
12:06 ET | 900 | 59.94 |
12:08 ET | 1366 | 59.905 |
12:10 ET | 331 | 59.915 |
12:12 ET | 1200 | 59.89 |
12:14 ET | 307 | 59.92 |
12:15 ET | 2039 | 59.818 |
12:17 ET | 4244 | 60.045 |
12:19 ET | 400 | 60.045 |
12:21 ET | 3200 | 59.96 |
12:24 ET | 800 | 59.888 |
12:26 ET | 788 | 59.86 |
12:28 ET | 1300 | 59.8 |
12:30 ET | 400 | 59.805 |
12:32 ET | 300 | 59.8 |
12:33 ET | 300 | 59.855 |
12:35 ET | 1400 | 59.86 |
12:37 ET | 225 | 59.865 |
12:39 ET | 2000 | 59.975 |
12:42 ET | 200 | 60 |
12:44 ET | 4000 | 59.99 |
12:46 ET | 500 | 59.985 |
12:48 ET | 100 | 59.935 |
12:50 ET | 2689 | 60.02 |
12:51 ET | 100 | 60.015 |
12:53 ET | 855 | 59.96 |
12:55 ET | 2420 | 60.07 |
12:57 ET | 600 | 60.06 |
01:00 ET | 1500 | 60.32 |
01:02 ET | 1300 | 60.25 |
01:04 ET | 1410 | 60.19 |
01:06 ET | 900 | 60.26 |
01:08 ET | 500 | 60.17 |
01:09 ET | 738 | 60.09 |
01:11 ET | 500 | 60.13 |
01:13 ET | 600 | 60.17 |
01:15 ET | 900 | 60.245 |
01:18 ET | 1700 | 60.165 |
01:20 ET | 200 | 60.185 |
01:22 ET | 600 | 60.19 |
01:24 ET | 200 | 60.185 |
01:27 ET | 1600 | 60.225 |
01:29 ET | 1900 | 60.26 |
01:31 ET | 1941 | 60.13 |
01:33 ET | 1100 | 60.23 |
01:36 ET | 100 | 60.23 |
01:38 ET | 200 | 60.225 |
01:40 ET | 1200 | 60.17 |
01:42 ET | 1100 | 59.955 |
01:44 ET | 930 | 59.925 |
01:45 ET | 100 | 59.925 |
01:47 ET | 400 | 59.905 |
01:49 ET | 500 | 59.88 |
01:51 ET | 2568 | 59.99 |
01:54 ET | 3845 | 60.05 |
01:56 ET | 2744 | 60.135 |
01:58 ET | 1000 | 60.11 |
02:00 ET | 1400 | 60.08 |
02:02 ET | 600 | 59.98 |
02:03 ET | 2100 | 60.03 |
02:05 ET | 200 | 60.01 |
02:07 ET | 600 | 60.06 |
02:09 ET | 1100 | 59.9825 |
02:12 ET | 1100 | 59.96 |
02:14 ET | 100 | 60 |
02:16 ET | 1084 | 59.92 |
02:18 ET | 700 | 59.95 |
02:20 ET | 400 | 59.98 |
02:21 ET | 200 | 59.96 |
02:23 ET | 2054 | 60.03 |
02:25 ET | 1124 | 59.98 |
02:27 ET | 500 | 60.03 |
02:30 ET | 400 | 60.02 |
02:32 ET | 1200 | 60.005 |
02:34 ET | 100 | 60.005 |
02:36 ET | 500 | 60.01 |
02:38 ET | 200 | 59.96 |
02:39 ET | 800 | 59.91 |
02:41 ET | 400 | 59.92 |
02:43 ET | 600 | 59.935 |
02:45 ET | 2094 | 59.885 |
02:48 ET | 500 | 59.905 |
02:50 ET | 600 | 59.89 |
02:52 ET | 500 | 59.945 |
02:54 ET | 400 | 59.9 |
02:56 ET | 741 | 59.87 |
02:57 ET | 1200 | 59.79 |
02:59 ET | 1300 | 59.87 |
03:01 ET | 400 | 59.89 |
03:03 ET | 1900 | 59.955 |
03:06 ET | 700 | 59.9 |
03:08 ET | 1150 | 59.88 |
03:10 ET | 400 | 59.945 |
03:12 ET | 500 | 59.98 |
03:14 ET | 16412 | 60.07 |
03:15 ET | 1900 | 60 |
03:17 ET | 16100 | 60.21 |
03:19 ET | 1718 | 60.1499 |
03:21 ET | 3070 | 59.85 |
03:24 ET | 400 | 59.95 |
03:26 ET | 1351 | 59.955 |
03:28 ET | 2000 | 59.97 |
03:30 ET | 2093 | 59.97 |
03:32 ET | 1782 | 59.995 |
03:33 ET | 2035 | 59.9625 |
03:35 ET | 1900 | 59.955 |
03:37 ET | 1900 | 59.94 |
03:39 ET | 3509 | 59.93 |
03:42 ET | 4087 | 59.99 |
03:44 ET | 5146 | 59.99 |
03:46 ET | 4065 | 59.93 |
03:48 ET | 5215 | 59.95 |
03:50 ET | 5604 | 59.97 |
03:51 ET | 11520 | 59.965 |
03:53 ET | 17489 | 60.075 |
03:55 ET | 20333 | 60.15 |
03:57 ET | 19331 | 60.17 |
04:00 ET | 29538 | 60.29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Intra-Cellular Therapies Inc | 5.8B | -37.1x | --- |
BridgeBio Pharma Inc | 5.7B | -8.3x | --- |
Immunovant Inc | 5.7B | -20.0x | --- |
Vaxcyte Inc | 5.4B | -17.2x | --- |
Blueprint Medicines Corp | 4.5B | -8.0x | --- |
CRISPR Therapeutics AG | 5.1B | -14.4x | --- |
Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company’s product CAPLYTA is a treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as monotherapy and as adjunctive therapy with lithium or valproate. The efficacy of CAPLYTA 42 mg in bipolar depression was demonstrated in two positive Phase III placebo-controlled bipolar depression studies, which evaluated the effects of CAPLYTA on depression in adult patients with bipolar I or bipolar II disorder both as monotherapy (Study 404) and as adjunctive therapy with lithium or valproate (Study 402).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.8B |
---|---|
Revenue (TTM) | $420.1M |
Shares Outstanding | 96.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.00 |
EPS | $-1.63 |
Book Value | $6.92 |
P/E Ratio | -37.1x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -41.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.